Back
Intellia Therapeutics Stock Price Chart
Sell
45
NTLA
Intellia Therapeutics
Last Price:
26.24
Seasonality Move:
33.25%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NTLA is experiencing slight buying pressure.
Intellia Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.26 | Buy |
| 20-day SMA: | 23.39 | Buy |
| 50-day SMA: | 24.93 | Buy |
| 200-day SMA: | 29.22 | Sell |
| 8-day EMA: | 25.36 | Buy |
| 20-day EMA: | 24.39 | Buy |
| 50-day EMA: | 24.9 | Buy |
| 200-day EMA: | 29.74 | Sell |
Intellia Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.51 | Buy |
| Relative Strength Index (14 RSI): | 62.46 | Buy |
| Chaikin Money Flow: | 117641 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.24 - 24.92) | Buy |
| Bollinger Bands (100): | (23.55 - 29.45) | Sell |
Intellia Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intellia Therapeutics Stock
Is Intellia Therapeutics Stock a Buy?
- Intellia Therapeutics share price is 26.22 while NTLA 8-day simple moving average is 25.26, which is a Buy signal.
- The stock price of NTLA is 26.22 while Intellia Therapeutics 20-day SMA is 23.39, which makes it a Buy.
- Intellia Therapeutics 50-day simple moving average is 24.93 while NTLA share price is 26.22, making it a Buy technically.
- NTLA stock price is 26.22 and Intellia Therapeutics 200-day simple moving average is 29.22, creating a Sell signal.
NTLA Technical Analysis vs Fundamental Analysis
Sell
45
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy or a Sell?
-
Intellia Therapeutics stock is rated a Sell
The current Intellia Therapeutics [NTLA] share price is $26.22. The Score for NTLA is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Intellia Therapeutics Stock Info
Market Cap:
2.53B
Price in USD:
26.22
Share Volume:
1.09M
Intellia Therapeutics 52-Week Range
52-Week High:
47.48
52-Week Low:
19.37
Sell
45
Intellia Therapeutics (NTLA)
is a Sell
Intellia Therapeutics Share Price Forecast
-
What is the Intellia Therapeutics stock price today?
The Intellia Therapeutics stock price is 26.22 USD today. -
Will NTLA stock go up or go down?
Intellia Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Intellia Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intellia Therapeutics is overvalued.
Is Intellia Therapeutics Stock a Buy?
- Intellia Therapeutics share price is 26.22 while NTLA 8-day exponential moving average is 25.36, which is a Buy signal.
- The stock price of NTLA is 26.22 while Intellia Therapeutics 20-day EMA is 24.39, which makes it a Buy.
- Intellia Therapeutics 50-day exponential moving average is 24.90 while NTLA share price is 26.22, making it a Buy technically.
- NTLA stock price is 26.22 and Intellia Therapeutics 200-day simple moving average is 29.74, creating a Sell signal.
Fundamental Analysis of Intellia Therapeutics
Is Intellia Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.26 per share, and a decrease next year of $0.19 per share.
Technical Analysis of Intellia Therapeutics
Should I short Intellia Therapeutics stock?
- NTLA Moving Average Covergence Divergence (MACD) indicator is 0.51, suggesting Intellia Therapeutics is a Buy
- Intellia Therapeutics Relative Strength Index (RSI) is 62.46, which suggest Intellia Therapeutics is overbought
- The Bollinger Bands (25) for Intellia Therapeutics is (21.24 - 24.92), which suggest Intellia Therapeutics is a Sell
- The Bollinger Bands (100) for Intellia Therapeutics is (23.55 - 29.45), which suggest Intellia Therapeutics is a Sell
* Intellia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.